Peptide Schedule Research TeamReviewed Apr 20267 Citations
CJC-1295 (No DAC)29 residuesYDADIFTQSYRKVLAQLSARKLLQDILSREach bubble = one amino acid. Size = residue mass. Color = chemical class.Adjust vial, water, and dose — answer updates live
on a U-100 syringe for a 100mcg dose
Never miss a dose — 100mcg daily, draw 10.0 units on U-100 syringe.
No signup required to use calculator
Sync to any calendar app
CJC-1295 (No DAC) triggers natural GH pulses with a 30-minute half-life. Paired with Ipamorelin in most protocols, it's the community's preferred GHRH analog for sleep, recovery, and body composition. No clinical trials of any kind exist for this specific form.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 100mcg | Daily |
| Moderate | 100mcg | 2x Daily |
| Aggressive | 200mcg | 2x Daily |
Mod GRF 1-29 needs to be co-injected with a GHRP to do much. Solo use rarely moves IGF-1 meaningfully; the community discourages it. Ipamorelin at 100 mcg co-injected is the standard pairing. Reconstitution math for common vial sizes. A 2 mg vial with 2 mL bacteriostatic water gives you 1,000 mcg/mL. A 100 mcg dose is 10 units on an insulin syringe (0.1 mL). A 5 mg vial with 2 mL bacteriostatic water gives you 2,500 mcg/mL. A 100 mcg dose is 4 units (0.04 mL); a 200 mcg dose is 8 units (0.08 mL). The fasting window is non-negotiable. Two hours minimum with no food before injection; 30 minutes after. Insulin raises somatostatin, which shuts down the GH pulse completely. This is the number-one troubleshooting issue when users report no IGF-1 movement after weeks on protocol. Check fasting compliance before blaming the vendor. Abdominal subcutaneous injection absorbs faster than thigh or flank. For a compound with a 30-minute active window, that speed matters.
Dosing based on Community dosing consensus from peptide research communities — 11 published references.View all sources →
Cross-check your CJC-1295 (No DAC) reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
